In our previous study including 128 patients with MM diagnosed de novo, we noted a higher risk of death in the carriers of the TT genotype (rs2278911; 686C>T) of the KIAA1524 gene (mOS: 8 months vs. 45 months; HR = 0.53). The gene discussed is CIP2A; the disease is Miyoshi myopathy.